Human Liver Diseases and Hepatocyte In Vitro Cell Culture Model
The human liver is a remarkable organ with vital functions that impact metabolism, detoxification, and protein synthesis. Understanding liver [...]
The human liver is a remarkable organ with vital functions that impact metabolism, detoxification, and protein synthesis. Understanding liver [...]
Drug discovery is a complex process that involves identifying and developing new drugs to treat a wide range of [...]
Non-alcoholic steatohepatitis (NASH) is a progressive disease which results in advancement of liver fibrosis, cirrhosis, and hepatocellular carcinoma, for which [...]
Nonalcoholic fatty liver disease (NAFLD) is a common hepatic disorder in individuals who drink little or no alcohol. A [...]
Non-alcoholic fatty liver disease (NAFLD) is the most chronic form of liver disease, which affects about quarter of the [...]
Non-alcoholic fatty liver disease (NAFLD) is a common condition and estimates indicate almost 1 in 4 adults in the [...]
Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]
Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation, cell injury and fibrosis. Progression of this [...]
Did you miss our NASH 3D cell culture webinar with Corning and Molecular Devices on October 14th? If [...]
In this webinar, we’ve partnered with Molecular Devices and Corning to present a case study for integrating novel [...]